Capricor Therapeutics, Inc. (CAPR)

24.96 +0.24 (+0.97%) USD  |  NASDAQ  |  Feb 09, 11:50
More

Capricor Therapeutics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for CAPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Inovio Pharmaceuticals, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Arcturus Therapeutics Holdings, Inc. Upgrade
Myomo, Inc. Upgrade